RU2009109060A - A COMPOSITION CONTAINING HUMAN RECOMBINANT ALPHA-2B INTERFERON AND A LONG-TREATED MEDICINAL PRODUCT FOR VETERINARIUM WITH ITS ANTI-VIRUS IMERIUM - Google Patents
A COMPOSITION CONTAINING HUMAN RECOMBINANT ALPHA-2B INTERFERON AND A LONG-TREATED MEDICINAL PRODUCT FOR VETERINARIUM WITH ITS ANTI-VIRUS IMERIUM Download PDFInfo
- Publication number
- RU2009109060A RU2009109060A RU2009109060/15A RU2009109060A RU2009109060A RU 2009109060 A RU2009109060 A RU 2009109060A RU 2009109060/15 A RU2009109060/15 A RU 2009109060/15A RU 2009109060 A RU2009109060 A RU 2009109060A RU 2009109060 A RU2009109060 A RU 2009109060A
- Authority
- RU
- Russia
- Prior art keywords
- antibiotic
- dextran
- drug
- drug according
- composition according
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract 15
- 108010050904 Interferons Proteins 0.000 title claims abstract 3
- 102000014150 Interferons Human genes 0.000 title claims abstract 3
- 229940079322 interferon Drugs 0.000 title claims abstract 3
- 230000002155 anti-virotic effect Effects 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 claims abstract 12
- 229940079593 drug Drugs 0.000 claims abstract 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims abstract 9
- 230000003115 biocidal effect Effects 0.000 claims abstract 9
- 229920002307 Dextran Polymers 0.000 claims abstract 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract 6
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims abstract 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract 6
- 239000007924 injection Substances 0.000 claims abstract 5
- 238000002347 injection Methods 0.000 claims abstract 5
- 108010040201 Polymyxins Proteins 0.000 claims abstract 4
- 229940126575 aminoglycoside Drugs 0.000 claims abstract 4
- 239000003782 beta lactam antibiotic agent Substances 0.000 claims abstract 4
- 229940124307 fluoroquinolone Drugs 0.000 claims abstract 4
- 229940041153 polymyxins Drugs 0.000 claims abstract 4
- 229940124530 sulfonamide Drugs 0.000 claims abstract 4
- 150000003456 sulfonamides Chemical class 0.000 claims abstract 4
- 229940072172 tetracycline antibiotic Drugs 0.000 claims abstract 4
- 239000002132 β-lactam antibiotic Substances 0.000 claims abstract 4
- 229940124586 β-lactam antibiotics Drugs 0.000 claims abstract 4
- 108010078049 Interferon alpha-2 Proteins 0.000 claims abstract 3
- 229960003507 interferon alfa-2b Drugs 0.000 claims abstract 3
- 229920000609 methyl cellulose Polymers 0.000 claims abstract 3
- 239000001923 methylcellulose Substances 0.000 claims abstract 3
- 235000010981 methylcellulose Nutrition 0.000 claims abstract 3
- 239000001103 potassium chloride Substances 0.000 claims abstract 3
- 235000011164 potassium chloride Nutrition 0.000 claims abstract 3
- 239000011780 sodium chloride Substances 0.000 claims abstract 3
- 239000012064 sodium phosphate buffer Substances 0.000 claims abstract 3
- MIXCUJKCXRNYFM-UHFFFAOYSA-M sodium;diiodomethanesulfonate;n-propyl-n-[2-(2,4,6-trichlorophenoxy)ethyl]imidazole-1-carboxamide Chemical compound [Na+].[O-]S(=O)(=O)C(I)I.C1=CN=CN1C(=O)N(CCC)CCOC1=C(Cl)C=C(Cl)C=C1Cl MIXCUJKCXRNYFM-UHFFFAOYSA-M 0.000 claims abstract 3
- 239000000243 solution Substances 0.000 claims abstract 3
- 239000003242 anti bacterial agent Substances 0.000 claims abstract 2
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract 2
- 230000000840 anti-viral effect Effects 0.000 claims abstract 2
- 239000000872 buffer Substances 0.000 claims abstract 2
- 230000002209 hydrophobic effect Effects 0.000 claims abstract 2
- 230000002519 immonomodulatory effect Effects 0.000 claims abstract 2
- 229920000642 polymer Polymers 0.000 claims abstract 2
- 150000003839 salts Chemical class 0.000 claims abstract 2
- 239000008174 sterile solution Substances 0.000 claims abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract 2
- 239000008215 water for injection Substances 0.000 claims abstract 2
- 239000001913 cellulose Substances 0.000 claims 2
- 229920002678 cellulose Polymers 0.000 claims 2
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
1. Композиция, обладающая противовирусным, иммуномодулирующим и антибактериальным действием, содержащая гидрофобный комплекс интерферона с двумя полимерами - декстраном и метилцеллюлозой, и антибиотик. ! 2. Композиция по п.1, отличающаяся тем, что используют декстран с молярной массой 30000 или 60000, или их смесь. ! 3. Композиция по п.1, отличающаяся тем, что в качестве антибиотика используют антибиотики тетрациклинового ряда, аминогликозиды, бета-лактамные антибиотики, полимиксины, фторхинолоны, сульфаниламиды. ! 4. Композиция по п.1, отличающаяся тем, что такая композиция дополнительно содержит солевой буфер для стабилизации pH в районе 5,0-7,5. ! 5. Лекарственное средство, содержащее композицию по любому из пп.1-4. ! 6. Лекарственное средство по п.5, отличающееся тем, что в качестве антибиотика используют антибиотики тетрациклинового ряда, аминогликозиды, бета-лактамные антибиотики, полимиксины, фторхинолоны, сульфаниламиды. ! 7. Лекарственное средство по п.5, отличающееся тем, что указанное средство представляет собой стерильный раствор для инъекций. ! 8. Лекарственное средство по п.7, отличающееся тем, что используют следующее соотношение компонентов, на мл: ! человеческий рекомбинантный интерферон альфа-2b 10-200 млн. ME декстран 5-10 мг метилцеллюлоза 1-20 мг антибиотик 1-200 мг натрий фосфатный буфер 50 ммоль натрий хлористый 8,7 мг калий хлористый 0,3 мг кислота соляная или натрия гидроксид до pH 5,0-7,5 вода для инъекций до 1 мл ! 9. Лекарственное средство по п.5, отличающееся тем, что указанное средство представляет собой стерильный лиофилизат для приготовления раствора для инъекций. ! 10. Лекарственное средство по п.9, от 1. A composition having antiviral, immunomodulatory and antibacterial action, containing a hydrophobic complex of interferon with two polymers - dextran and methyl cellulose, and an antibiotic. ! 2. The composition according to claim 1, characterized in that the use of dextran with a molar mass of 30,000 or 60,000, or a mixture thereof. ! 3. The composition according to claim 1, characterized in that tetracycline antibiotics, aminoglycosides, beta-lactam antibiotics, polymyxins, fluoroquinolones, sulfonamides are used as antibiotic. ! 4. The composition according to claim 1, characterized in that such a composition further comprises a salt buffer to stabilize the pH in the region of 5.0-7.5. ! 5. A drug containing a composition according to any one of claims 1 to 4. ! 6. The drug according to claim 5, characterized in that tetracycline antibiotics, aminoglycosides, beta-lactam antibiotics, polymyxins, fluoroquinolones, sulfonamides are used as antibiotic. ! 7. The drug according to claim 5, characterized in that the tool is a sterile solution for injection. ! 8. The drug according to claim 7, characterized in that the following ratio of components is used, per ml:! human recombinant interferon alfa-2b 10-200 ppm ME dextran 5-10 mg methyl cellulose 1-20 mg antibiotic 1-200 mg sodium phosphate buffer 50 mmol sodium chloride 8.7 mg potassium chloride 0.3 mg hydrochloric acid or sodium hydroxide pH 5.0-7.5 water for injection up to 1 ml! 9. The drug according to claim 5, characterized in that the tool is a sterile lyophilisate for the preparation of a solution for injection. ! 10. The drug according to claim 9, from
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2009109060/15A RU2404798C1 (en) | 2009-03-13 | 2009-03-13 | COMPOSITION CONTAINING HUMAN RECOMBINANT INTERFERON ALPHA-2b, AND MEDICINAL AGENT OF PROLONGED ACTION FOR VETERINARY SCIENCE ON ITS BASIS, HAVING ANTIVIRUS, IMMUNOMODULATORY AND ANTIBACTERIAL ACTION |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2009109060/15A RU2404798C1 (en) | 2009-03-13 | 2009-03-13 | COMPOSITION CONTAINING HUMAN RECOMBINANT INTERFERON ALPHA-2b, AND MEDICINAL AGENT OF PROLONGED ACTION FOR VETERINARY SCIENCE ON ITS BASIS, HAVING ANTIVIRUS, IMMUNOMODULATORY AND ANTIBACTERIAL ACTION |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2009109060A true RU2009109060A (en) | 2010-09-20 |
| RU2404798C1 RU2404798C1 (en) | 2010-11-27 |
Family
ID=42938817
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2009109060/15A RU2404798C1 (en) | 2009-03-13 | 2009-03-13 | COMPOSITION CONTAINING HUMAN RECOMBINANT INTERFERON ALPHA-2b, AND MEDICINAL AGENT OF PROLONGED ACTION FOR VETERINARY SCIENCE ON ITS BASIS, HAVING ANTIVIRUS, IMMUNOMODULATORY AND ANTIBACTERIAL ACTION |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2404798C1 (en) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2095081C1 (en) * | 1991-12-13 | 1997-11-10 | Акционерное общество "Биофа" | Antiviral pharmaceutical composition |
| RU2187332C1 (en) * | 2000-12-18 | 2002-08-20 | Гапонюк Петр Яковлевич | Curative agent |
| RU2292907C1 (en) * | 2006-03-03 | 2007-02-10 | Станислав Степанович Афанасьев | Composition possessing antiviral and antibacterial effect |
-
2009
- 2009-03-13 RU RU2009109060/15A patent/RU2404798C1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2404798C1 (en) | 2010-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2010114009A (en) | APPLICATION OF RGDSPASSKP AND OPTIONAL ANGIOTENZINE II AS A THERAPEUTIC MEDICINE FOR TREATMENT, FOR EXAMPLE, INFECTIONS OF S. PNEUMONIAE | |
| RU2013108857A (en) | COMPOUNDS FOR TREATMENT / PREVENTION OF INFLAMMATORY EYE DISEASES | |
| RU2011153353A (en) | KETOLIDE COMPOUNDS WITH ANTI-MICROBIAL ACTIVITY | |
| MY199821A (en) | Modified lipidated relaxin b chain peptides and their therapeutic use | |
| IL278717B1 (en) | Initial dose of PTH conjugates | |
| RU2010129824A (en) | NEW functionally active, highly purified, stable Alpha interferon conjugate with polyethylene glycol, represented by one of positional isomers of PEG-IFN-NAH with reduced immunogenicity, with a prolonged biological effect are suitable for medical applications, and immunobiological agent based on ITS | |
| RU2008139633A (en) | DRUG COMPOSITIONS CONTAINING Fluoroquinolones | |
| RU2012109392A (en) | PHARMACEUTICAL COMPOSITION FOR REDUCING PAIN | |
| JPS63146829A (en) | Stable granulocyte colony stimulating factor-containing preparation | |
| RU2009109060A (en) | A COMPOSITION CONTAINING HUMAN RECOMBINANT ALPHA-2B INTERFERON AND A LONG-TREATED MEDICINAL PRODUCT FOR VETERINARIUM WITH ITS ANTI-VIRUS IMERIUM | |
| BG65662B1 (en) | Pharmaceutical agent containing a benzamide derivative as an active ingredient | |
| RU2013157933A (en) | COMPOSITIONS, INCLUDING ANTIBACTERIAL MEANS AND PERSPECTIVES | |
| SI2887953T1 (en) | Improved daptomycin injectable formulation | |
| RU2009109059A (en) | A COMPOSITION CONTAINING A HUMAN RECOMBINANT ALPHA-2B INTERFERON AND A LONG-TREATED MEDICINE FOR VETERINARY USE THEREOF | |
| RU2010141697A (en) | METHOD FOR OBTAINING SODIUM CARBOXYMETHYL CELLULOSE AND GOSSYPOL COPOLYMER AND ITS APPLICATION IN COMPLEX THERAPY OF PATIENTS WITH AUTISTIC DISORDERS AND COGNITIVE DISORDERS | |
| ES2524454T3 (en) | G-CSF liquid formulation | |
| CN103880930A (en) | Vancomycin derivative as well as preparation method and pharmaceutical use thereof | |
| RU2015100116A (en) | TIGECYCLINE INJECTION COMPOSITION | |
| RU2010129409A (en) | METHOD FOR TREATING RABBIT PSOROPTOSIS AND CARNIVOR ANIMAL OTODEKTOSIS | |
| RU2015114709A (en) | STABLE INJECTION COMPOSITION CONTAINING DICLOFENAC AND THIOCOLCHICOSIDE | |
| EA201400830A1 (en) | ANTIBACTERIAL PHARMACEUTICAL COMPOSITION | |
| RU2013124416A (en) | DIINDOLYLMETHANE MEDICINAL PRODUCT AND ITS APPLICATION FOR TREATMENT OF INFLUENZA AND RESPIRATORY VIRAL INFECTIONS | |
| RU2015111491A (en) | COMBINATION OF THE MACROCYCLIC HCV PROTEASE INHIBITOR, HCV NON-NUCLEOSIDE INHIBITOR AND RITONAVIR | |
| KR20070012522A (en) | Treatment and prevention of respiratory viral infections with immunomodulatory compounds | |
| RU2008126108A (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF OSTEOARTHRITIS CONTAINING CLODRONIC ACID AND HYALURONIC ACID |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20130314 |
|
| NF4A | Reinstatement of patent |
Effective date: 20140910 |
|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20170314 |
|
| NF4A | Reinstatement of patent |
Effective date: 20180205 |
|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20210314 |